Table 1.

The relationship between clinicoathological parameters and expression of BCL6

Clinicopathological Features		N	%	BCL6 Expression				Rho value	P value
				0	1	2	3
All cases		105	100	19	24	22	40
Age (years)	< 40	59	32.17	14	16	6	23	0.125	0.203
(Average 57.6)	≥ 40	46	57.14	5	8	16	17
Tumor size	< 5 cm	57	54.29	9	20	13	15	0.191	0.05*
	≥ 5 cm	48	45.71	7	10	7	24
Histological types	Serous	43	40.92	10	8	3	22	-0.166	0.091
	Endometrioid	31	29.52	2	9	6	14
	Clear Cell	31	19.52	4	14	11	3
FIGO Stage	I	47	42.86	13	21	3	10	0.43	< 0.001*
	II	32	30.48	3	4	8	17
	III, IV	26	24.76	0	5	9	12
Lymph node metastasis	-	89	84.76	16	27	16	30	0.225	0.021*
	+	16	15.24	0	3	4	9
Remote metastasis	-	103	98.1	16	30	20	37	0.159	0.106
	+	2	1.9	0	0	0	2
Recurrence	-	78	74.3	18	28	10	25	0.308	0.001*
	+	27	25.7	1	2	10	14

N, number of patients;

^*p < 0.05.